Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Metabolic profiling links cardiovascular risk and vascular end organ damage
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4625666
Author(s) Streese, Lukas; Springer, Anna Maria; Deiseroth, Arne; Carrard, Justin; Infanger, Denis; Schmaderer, Christoph; Schmidt-Trucksäss, Arno; Madl, Tobias; Hanssen, Henner
Author(s) at UniBasel Carrard, Justin
Streese, Lukas
Year 2021
Title Metabolic profiling links cardiovascular risk and vascular end organ damage
Journal Atherosclerosis
Volume 331
Pages / Article-Number 45-53
Keywords Ageing; Cardiovascular risk; Metabolomics; Screening; Vascular function
Mesh terms Cardiovascular Diseases, epidemiology; Heart Disease Risk Factors; Humans; Metabolomics; Pulse Wave Analysis; Risk Factors
Abstract An untargeted metabolomics approach allows for a better understanding and identification of new candidate metabolites involved in the etiology of vascular disease. We aimed to investigate the associations of cardiovascular (CV) risk factors with the metabolic fingerprint and macro- and microvascular health in an untargeted metabolomic approach in predefined CV risk groups of aged individuals.; The metabolic fingerprint and the macro- and microvascular health from 155 well-characterized aged (50-80 years) individuals, based on the EXAMIN AGE study, were analysed. Nuclear magnetic resonance spectroscopy was used to analyse the metabolic fingerprint. Carotid-femoral pulse wave velocity and retinal vessel diameters were assessed to quantify macro- and microvascular health.; The metabolic fingerprint became more heterogeneous with an increasing number of risk factors. There was strong evidence for higher levels of glutamine [estimate (95% CI): -14.54 (-17.81 to -11.27), p < 0.001], glycine [-5.84 (-7.88 to -3.79), p < 0.001], histidine [-0.73 (-0.96 to -0.50), p < 0.001], and acetate [-1.68 (-2.91 to -0.46), p = 0.007] to be associated with a lower CV risk profile. Tryptophan, however, was positively associated with higher CV risk [0.31 (0.06-0.56), p = 0.015]. The combination of a priori defined CV risk factors explained up to 45.4% of the metabolic variation. The metabolic fingerprint explained 20% of macro- and 23% of microvascular variation.; Metabolic profiling has the potential to improve CV risk stratification by identifying new underlying metabolic pathways associated with atherosclerotic disease development, from cardiovascular risk to metabolites, to vascular end organ damage.
Publisher Elsevier
ISSN/ISBN 1879-1484
edoc-URL https://edoc.unibas.ch/85138/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.atherosclerosis.2021.07.005
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/34344526
ISI-Number WOS:000693712700010
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.322 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
12/05/2024